InsidersTradesSigma
Discover the complete record of transactions filed by Zhang Xiaoyan Michelle, Directeur Scientifique. Director active across 1 company, notably Ikena Oncology, Inc.. Aggregated, 4 disclosures have been logged. Activity tracked since 10 December 2021. The latest transaction was disclosed on 10 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations
Michelle Zhang Xiaoyan is the Chief Scientific Officer at Ikena Oncology, Inc. She oversees research and development programs, contributing to innovation in the field of oncology. Her expertise is essential for the success of the company's projects.